image
Healthcare - Biotechnology - NASDAQ - US
$ 51.8
-4.22 %
$ 2.23 B
Market Cap
-18.57
P/E
BALANCE SHEET
181 M ASSETS
581.93%
23.2 M LIABILITIES
43.56%
158 M EQUITY
1422.10%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Soleno Therapeutics, Inc.
image
Current Assets 171 M
Cash & Short-Term Investments 170 M
Receivables 0
Other Current Assets 1.68 M
Non-Current Assets 9.33 M
Long-Term Investments 0
PP&E 419 K
Other Non-Current Assets 8.91 M
Current Liabilities 11.5 M
Accounts Payable 3.15 M
Short-Term Debt 546 K
Other Current Liabilities 7.81 M
Non-Current Liabilities 11.7 M
Long-Term Debt 130 K
Other Non-Current Liabilities 11.5 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 169.7 14.6 21.3 49.2 20.7 23.1 17.1 2.7 5.5 8.0 1.3 2.2
Short Term Investments 0 0 0 0 0 1.0 0 0 0 0 0 0
Receivables 0 0 0 0 0 64 K 0 0 0.2 0 0.1 0.2
Inventory 0 0 0 0 0 0 0 0.7 0.6 0.1 0 0
Other Current Assets 1.7 1.0 2.2 2.0 0.8 0.5 0.9 1.1 0.2 0.3 0.1 81.5 K
Total Current Assets 171.4 15.6 22.4 50.2 21.1 24.7 18.0 3.8 6.4 8.3 1.5 2.4
PP&E 0.4 0.2 0.5 0.2 0.4 12 K 22.9 K 0.1 85.7 K 57.6 K 63.2 K 0.1
Intangible Assets 8.7 10.7 12.6 14.6 16.5 18.5 20.4 0.8 0.9 0 0 0
Goodwill 0 0 0 0 0 0 0.1 0.7 0.7 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.2 0 40 K 0 59 K 0 0.6 0.1 76.3 K 0 0 21.1 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 180.7 26.5 35.6 65.0 38.2 43.2 39.0 5.6 8.2 8.4 1.6 2.5
LIABILITIES
Accounts Payable 3.1 1.8 3.3 3.5 2.0 0.9 0.6 0.4 0.5 1.0 57.7 K 0.2
Short Term Debt 0.5 0.3 0.6 0.1 0.3 0 0 0 0 0.1 14.0 11.1
Other Current Liabilities 7.8 5.2 4.2 5.0 2.7 0.9 1.1 1.3 2.7 0.2 0.1 0.2
Total Current Liabilities 11.5 7.3 8.0 8.6 5.0 1.9 1.7 1.7 3.2 1.3 14.2 11.5
Long Term Debt 0.1 0 0.2 0 0 0 0 0 0 0 1.5 1.4
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 11.5 8.8 9.6 10.8 18.3 10.9 10.5 0.4 1.8 17.4 23.8 23.8
Total Liabilities 23.2 16.1 17.8 19.4 23.2 12.7 12.5 2.1 5.0 18.7 39.5 36.7
EQUITY
Common Stock 32 K 8 K 80 K 80 K 45 K 32 K 19.2 K 16.8 K 14 K 6.77 K 536 522
Retained Earnings (276.4) (237.4) (213.4) (182.4) (157.8) (127.0) (114.0) (98.3) (86.2) (71.0) (57.1) (53.4)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 93 K 73.6 K (0.2) (0.2) (0.1) (0.2) (0.2)
Total Equity 157.5 10.3 17.8 45.5 14.9 30.4 26.5 3.4 3.2 (10.3) (37.9) (34.2)
Total Liabilities and Equity 180.7 26.5 35.6 65.0 38.2 43.2 39.0 5.6 8.2 8.4 1.6 2.5
SHARES OUTSTANDING
Common Shares Outstanding 16.5 8.4 5.3 4.2 2.3 1.4 0.6 0.2 0.1 16.9 K 18.7 K 18.7 K